Susan has 15 years experience as a European Patent Attorney and she is undaunted by even the most complex of innovative technologies in the Electronics sector. Susan is a strategic thinker adept at disentangling complex legal scenarios in European patent law and formulating clear risk-evaluated options for resolving them.
Susan enjoys advocacy and has achieved good results for clients at Oral Proceedings at the European Patent Office at Opposition and before the Examining Division.
Susan's technical specialisms include software, processor and memory hardware, semiconductor technology, video and audio technology, wireless telecoms, consumer electronics, medical devices/software and Artificial Intelligence.
She aims to deliver to her clients excellence in both technical and legal aspects of patent drafting, prosecution and Opposition work.
Physics & Astronomy
Computational Quantum Theory
Susan is a member of the ChIPS community whose purpose is to advance women in technology, law and policy. She likes to inspire younger women to embrace a career in intellectual property and to pursue science at University.
Susan attends University careers fairs to educate new graduates and postgraduates about the opportunities available via pursuit of a career in intellectual property.
Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …Read article
Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …Read article
The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …Read article
Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …Read article
Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …Read article
To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …Read article
HGF in Europe and Knobbe Martens in the US are holding a joint webinar on 9th June. In this webinar we will explore considerations for implementing an effective strategy to …Event details
If you would like to discuss how HGF could help you, contact one of our IP specialists.